Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.278 USD | +0.72% | -6.77% | -88.21% |
May. 09 | GlycoMimetics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 07 | Capital One Downgrades GlycoMimetics to Equalweight, Price Target at $0.50 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-88.21% | 17.79M | |
+7.14% | 111B | |
+10.27% | 106B | |
-12.35% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-9.13% | 16.81B | |
+38.79% | 12.54B | |
-25.17% | 8.09B |
- Stock Market
- Equities
- GLYC Stock
- News GlycoMimetics, Inc.
- Transcript : GlycoMimetics, Inc., Q3 2021 Earnings Call, Nov 02, 2021